Trademark: 97335623
Word
FYSINQUO
Status
Pending
Status Code
732
Status Date
Wednesday, September 4, 2024
Serial Number
97335623
Mark Type
4
Filing Date
Tuesday, March 29, 2022
Published for Opposition
Tuesday, February 7, 2023

Trademark Owner History
Pfizer Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; Vaccines for human use

Trademark Events
Apr 1, 2022
New Application Entered
Apr 4, 2022
New Application Office Supplied Data Entered
Jan 4, 2023
Assigned To Examiner
Jan 4, 2023
Approved For Pub - Principal Register
Jan 18, 2023
Notification Of Notice Of Publication E-Mailed
Feb 7, 2023
Published For Opposition
Mar 28, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 7, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 28, 2023
Teas Change Of Correspondence Received
Apr 4, 2023
Noa E-Mailed - Sou Required From Applicant
Mar 28, 2023
Teas Change Of Owner Address Received
Sep 8, 2023
Sou Extension 1 Granted
Sep 8, 2023
Sou Teas Extension Received
Sep 8, 2023
Sou Extension 1 Filed
Mar 14, 2024
Notice Of Approval Of Extension Request E-Mailed
Sep 4, 2024
Sou Teas Extension Received
Sep 4, 2024
Notice Of Approval Of Extension Request E-Mailed
Sep 4, 2024
Sou Extension 3 Filed
Sep 4, 2024
Sou Extension 3 Granted
Sep 12, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 13, 2024
Sou Teas Extension Received
Mar 13, 2024
Sou Extension 2 Filed
Mar 13, 2024
Sou Extension 2 Granted

Trademark Alertz updated from USPTO on 2030-01-24